CF
LIMNW

Cantor Fitzgerald’s Liminatus Pharma Warrants LIMNW Stock Holding History

Cantor Fitzgerald’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-875,817
Closed -$210K – 610
2025
Q2 		$210K Buy
+875,817
New +$172K ﹤0.01% 302

Other funds holding LIMNW

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Cantor Fitzgerald's LIMNW Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Liminatus Pharma Warrants (LIMNW) in Q3 2025, closing a stake of 875,817 shares — an estimated $210K sold.

Cantor Fitzgerald first reported a position in LIMNW in Q2 2025 and held it in 1 quarter. The position peaked at $210K in Q2 2025. 26 funds tracked by Wall St. Rank hold LIMNW as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Liminatus Pharma Warrants position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 875,817 Liminatus Pharma Warrants shares in Q3 2025, an estimated $210K.
  • Cantor Fitzgerald first reported a position in Liminatus Pharma Warrants in Q2 2025 and held it in 1 quarter.
  • Cantor Fitzgerald's Liminatus Pharma Warrants position peaked at $210K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.